Siponimod fumaric acid

Red

Brand Name(s):Mayzent

Indication:Multiple Sclerosis

Rationale:1,2

Considered:Feb-20

Review Date:Jan-26

Comments:
NICE TA656 – Siponimod is recommended, within its marketing authorisation, as an option for treating secondary progressive multiple sclerosis with evidence of active disease